Karyotyping of Induced Pluripotent Stem Cells (iPSC) lines with Varying Sex Chromosome Dosage
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health Olao, under the Department of Health and Human Services, has issued a presolicitation notice for the karyotyping of Induced Pluripotent Stem Cells (iPSC) lines with varying sex chromosome dosage. This requirement is identified by solicitation number 75N98026Q01088 and is categorized as a notice of intent to sole source. The project falls under NAICS code 541990 and will be performed in Bethesda, Maryland. The response deadline for this opportunity is September 5, 2026, with the notice having been posted on August 26, 2026. There are no specific set-asides applied to this procurement. Michael L. Falzone serves as the primary point of contact for this effort.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Attachment One: Notice of Intent to Sole Source
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
